- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| RESPIRERX Aktie jetzt für 0€ handeln | |||||
| Di | RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties | 181 | GlobeNewswire (Europe) | Glen Rock, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. ("RespireRx" or the "Company"), a leader in the discovery and development of innovative and revolutionary treatments... ► Artikel lesen | |
| 20.11.25 | RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties | 230 | GlobeNewswire (Europe) | Glen Rock, N.J., Nov. 20, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (RespireRx or the Company), and its subsidiaries, EndeavourRx LLC (EndeavourRx) and ResolutionRx Ltd (ResolutionRx)... ► Artikel lesen | |
| 19.11.25 | RespireRx Pharmaceuticals Inc. Announces NIH/NINDS Grant Award and Amended and Restated Patent License Agreement | 279 | GlobeNewswire (Europe) | Glen Rock, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. ("RespireRx" or the "Company"), a leader in the discovery and development of innovative and revolutionary treatments... ► Artikel lesen | |
| 18.11.25 | RespireRx Pharmaceuticals Inc. Announces SEC Order Making Findings and Revoking Registration of Securities and Future Plans with respect to its Common Stock | 475 | GlobeNewswire (Europe) | Glen Rock, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. ("RespireRx", "RSPI", "Respondent" or the "Company"), a leader in the discovery and development of innovative and... ► Artikel lesen |
4 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DIGICANN VENTURES | 0,012 | +118,18 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| IONIS PHARMACEUTICALS | 48,200 | -1,33 % | Weekly Buzz: Johnson & Johnson, Vera Therapeutics Get FDA Nod; Vertex Pharmaceuticals Snaps Up Crinetics Pharmaceuticals; Satellos Bioscience Aces DMD Trial; Ionis Pharmaceuticals Misses Key Goal | NEW BRUNSWICK (dpa-AFX) - This week featured a steady stream of regulatory milestones, strategic dealmaking, and pivotal clinical trial updates, alongside missed trial goals across the biotech... ► Artikel lesen | |
| SINOPHARM | 1,898 | -0,11 % | SINOPHARM (01099): NOTICE OF BOARD MEETING | ||
| CSPC PHARMA | 0,945 | -1,76 % | CSPC PHARMA Receives USD10 million Milestone Payment From AstraZeneca | ||
| ORAMED PHARMACEUTICALS | 3,670 | -0,54 % | Oramed Pharmaceuticals Inc.: Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet | Significant Appreciation in Alpha Tau (NASDAQ: DRTS) Position (up ~$128 Million)
Scilex (NASDAQ: SCLX) Loan Substantially Repaid
Total Cash and Assets Build... ► Artikel lesen | |
| ADASTRA | 0,115 | -100,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 10,250 | -1,44 % | DesignRush: Brooke Sellas Joins DesignRush Podcast on Social Media's Revenue Risk | Miami, Florida--(Newsfile Corp. - June 23, 2026) - The latest episode of the DesignRush Podcast features Brooke Sellas, founder and CEO of B Squared Media. The episode explores why companies risk... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 441,00 | +0,05 % | Wolfe Research upgrades Madrigal Pharmaceuticals stock rating on Q2 beat | ||
| ACADIA PHARMACEUTICALS | 25,240 | -0,16 % | H.C. Wainwright reiterates Acadia Pharmaceuticals stock rating | ||
| CATALYST PHARMACEUTICALS | 27,300 | +2,63 % | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare DiseasesCompletion of the transaction gives Angelini Pharma ownership... ► Artikel lesen | |
| METRIOPHARM | - | - | Press Release: MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board | Press Release: MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board
-- Prof. Dr. med. Jürgen Braun joins the Scientific Advisory Board of
MetrioPharm... ► Artikel lesen | |
| BAYER | 49,810 | +0,83 % | DAX vor spannender Woche - und Rekorden? Bayer, Siemens Energy, Commerzbank und Allianz mit ... | Ungeachtet der geopolitischen Krisenherde könnte die überwiegend positiv aufgenommene Berichtssaison der DAX-Konzern auch in der neuen Woche Rückenwind verleihen. Sinkende Ölpreise und starke Quartalszahlen... ► Artikel lesen | |
| MERCK KGAA | 143,65 | -1,03 % | Neue Folge "Börse, Baby!": Earnings-Alarm: Jetzt entscheidet sich der KI-Boom | Die KI-Euphorie bekommt erste Risse: Trotz starker Quartalszahlen geraten Tech-Aktien kräftig unter Druck. Ist das noch eine gesunde Korrektur? Die Berichtssaison zeigt derzeit, wie hoch die Erwartungen... ► Artikel lesen | |
| NOVO NORDISK | 40,970 | -0,06 % | Novo Nordisk, Johnson & Johnson und Co. setzen auf Plattformen - warum einzelne Medikamente für Big Pharma längst nicht mehr ausreichen | ||
| PFIZER | 23,100 | -0,15 % | Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound |
RESPIRERX PHARMACEUTICALS INC gehört der Branche Pharma an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RESPIRERX PHARMACEUTICALS INC finden Sie auf Wallstreet Online.